HRP20130851T1 - Adicijske soli amina koji sadrže hidroksilne i/ili karboksilne grupe s derivatima aminonikotinske kiseline kao dhodh inhibitorima - Google Patents
Adicijske soli amina koji sadrže hidroksilne i/ili karboksilne grupe s derivatima aminonikotinske kiseline kao dhodh inhibitorimaInfo
- Publication number
- HRP20130851T1 HRP20130851T1 HRP20130851AT HRP20130851T HRP20130851T1 HR P20130851 T1 HRP20130851 T1 HR P20130851T1 HR P20130851A T HRP20130851A T HR P20130851AT HR P20130851 T HRP20130851 T HR P20130851T HR P20130851 T1 HRP20130851 T1 HR P20130851T1
- Authority
- HR
- Croatia
- Prior art keywords
- groups
- addition salts
- acid derivatives
- nicotinic acid
- carboxylic groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382031A EP2228367A1 (en) | 2009-03-13 | 2009-03-13 | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| PCT/EP2010/001550 WO2010102826A1 (en) | 2009-03-13 | 2010-03-11 | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130851T1 true HRP20130851T1 (hr) | 2013-10-25 |
Family
ID=40677683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130851AT HRP20130851T1 (hr) | 2009-03-13 | 2013-09-11 | Adicijske soli amina koji sadrže hidroksilne i/ili karboksilne grupe s derivatima aminonikotinske kiseline kao dhodh inhibitorima |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US20120014918A1 (hr) |
| EP (2) | EP2228367A1 (hr) |
| JP (1) | JP5674685B2 (hr) |
| KR (1) | KR101674699B1 (hr) |
| CN (1) | CN102348689B (hr) |
| AR (1) | AR075738A1 (hr) |
| AU (1) | AU2010223528B2 (hr) |
| BR (1) | BRPI1006766B8 (hr) |
| CA (1) | CA2754804C (hr) |
| CL (1) | CL2011002216A1 (hr) |
| CO (1) | CO6420337A2 (hr) |
| CY (1) | CY1114418T1 (hr) |
| DK (1) | DK2406225T3 (hr) |
| EA (1) | EA022350B1 (hr) |
| EC (1) | ECSP11011365A (hr) |
| ES (1) | ES2428746T3 (hr) |
| HK (1) | HK1162487A1 (hr) |
| HR (1) | HRP20130851T1 (hr) |
| IL (1) | IL214519A (hr) |
| ME (1) | ME01564B (hr) |
| MX (1) | MX2011009146A (hr) |
| MY (1) | MY155140A (hr) |
| NZ (1) | NZ594493A (hr) |
| PE (1) | PE20120171A1 (hr) |
| PL (1) | PL2406225T3 (hr) |
| PT (1) | PT2406225E (hr) |
| RS (1) | RS52949B (hr) |
| SG (1) | SG173823A1 (hr) |
| SI (1) | SI2406225T1 (hr) |
| SM (1) | SMT201300104B (hr) |
| TW (1) | TWI428127B (hr) |
| UA (1) | UA105786C2 (hr) |
| UY (1) | UY32467A (hr) |
| WO (1) | WO2010102826A1 (hr) |
| ZA (1) | ZA201105744B (hr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| EP2444088A1 (en) * | 2010-10-22 | 2012-04-25 | Almirall, S.A. | Amino derivatives for the treatment of proliferative skin disorders |
| EP2594271A1 (en) * | 2011-11-21 | 2013-05-22 | Almirall, S.A. | 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid for the treatment of psoriasis. |
| KR101251851B1 (ko) | 2011-11-30 | 2013-04-10 | 현대자동차주식회사 | Ｉｓｇ 시스템 및 이의 제어방법 |
| TW201350467A (zh) * | 2012-05-08 | 2013-12-16 | Teva Pharma | Ｎ－乙基－４－羥基－１－甲基－５－（甲基（２，３，４，５，６－五羥基己基）胺基）－２－側氧－ｎ－苯基－１，２－二氫喹啉－３－甲醯胺 |
| TW201400117A (zh) * | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
| US20160051679A1 (en) * | 2013-04-12 | 2016-02-25 | Actavis Group Ptc Ehf. | Pemetrexed Formulation |
| WO2018136009A1 (en) | 2017-01-20 | 2018-07-26 | Aslan Pharmaceuticals Pte Ltd | Combination therapy |
| WO2018136010A1 (en) | 2017-01-20 | 2018-07-26 | Aslan Pharmaceuticals Pte Ltd | Combination therapy |
| EP3590920A4 (en) * | 2017-03-02 | 2021-01-06 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences | AROMATIC FORMIATE 2-FTO INHIBITOR (SUBSTITUTED BENZENE MATRIX), PROCESS OF PREPARATION AND APPLICATIONS |
| AU2019359036A1 (en) | 2018-10-09 | 2021-06-03 | Aslan Pharmaceuticals Pte Ltd | Malonate salt of varlitinib |
| MA54541A (fr) * | 2018-12-21 | 2022-03-09 | Servier Lab | Formes cristallines et salines d'un composé organique et compositions pharmaceutiques associées |
| US20230390276A1 (en) * | 2020-10-15 | 2023-12-07 | Aslan Pharmaceuticals Pte. Ltd. | Treatment of autoimmune diseases with a dihydroorotate hehydrogenase (dhodh) inhibitor |
| CN114907267A (zh) * | 2021-02-08 | 2022-08-16 | 中国科学院上海药物研究所 | 用于抗肿瘤的药物组合 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3839344A (en) * | 1973-03-28 | 1974-10-01 | Schering Corp | N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid |
| GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
| SK17632001A3 (sk) * | 1999-06-10 | 2003-03-04 | Warner-Lambert Company | Liečivo na liečbu Alzheimerovej choroby, inhibíciu agregácie amyloidového proteínu a spôsob na zobrazenie depozít amyloidu |
| DK1381356T3 (da) | 2001-04-05 | 2008-09-22 | Aventis Pharma Inc | Anvendelse af (z)-z-cyano-3-hydroxy-but-2-enoinsyre-(4-trifluoromethylphenyl) - amide til behandling af multipel sclerose |
| WO2003006424A1 (en) | 2001-07-10 | 2003-01-23 | 4Sc Ag | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| JP2004099586A (ja) * | 2002-05-21 | 2004-04-02 | Sumitomo Pharmaceut Co Ltd | ジヒドロオロテートデヒドロゲナーゼ阻害剤 |
| WO2004056747A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| US20070219224A1 (en) | 2004-05-21 | 2007-09-20 | Uab Research Foundation, The | Compositions and Methods Relating to Pyrimidine Synthesis Inhibitors |
| WO2006022442A1 (ja) | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| WO2006044741A1 (en) | 2004-10-19 | 2006-04-27 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| JP2007015952A (ja) * | 2005-07-06 | 2007-01-25 | Shionogi & Co Ltd | ナフタレン誘導体 |
| ES2303758B1 (es) | 2006-02-20 | 2009-08-13 | Laboratorios Almirall S.A. | Nuevos derivados de piridin-3-amina. |
| ES2301380B1 (es) | 2006-08-09 | 2009-06-08 | Laboratorios Almirall S.A. | Nuevos derivados de 1,7-naftiridina. |
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) * | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
-
2009
- 2009-03-13 EP EP09382031A patent/EP2228367A1/en not_active Withdrawn
-
2010
- 2010-02-24 UY UY0001032467A patent/UY32467A/es active IP Right Grant
- 2010-03-08 TW TW099106617A patent/TWI428127B/zh active
- 2010-03-11 BR BRPI1006766A patent/BRPI1006766B8/pt active IP Right Grant
- 2010-03-11 NZ NZ594493A patent/NZ594493A/xx unknown
- 2010-03-11 AR ARP100100741A patent/AR075738A1/es not_active Application Discontinuation
- 2010-03-11 MY MYPI2011004300A patent/MY155140A/en unknown
- 2010-03-11 UA UAA201111802A patent/UA105786C2/uk unknown
- 2010-03-11 RS RS20130394A patent/RS52949B/en unknown
- 2010-03-11 CN CN201080011530.6A patent/CN102348689B/zh active Active
- 2010-03-11 ME MEP-2013-106A patent/ME01564B/me unknown
- 2010-03-11 CA CA2754804A patent/CA2754804C/en active Active
- 2010-03-11 EP EP10708932.8A patent/EP2406225B1/en active Active
- 2010-03-11 MX MX2011009146A patent/MX2011009146A/es active IP Right Grant
- 2010-03-11 PT PT107089328T patent/PT2406225E/pt unknown
- 2010-03-11 EA EA201101297A patent/EA022350B1/ru unknown
- 2010-03-11 SI SI201030344T patent/SI2406225T1/sl unknown
- 2010-03-11 PE PE2011001599A patent/PE20120171A1/es active IP Right Grant
- 2010-03-11 ES ES10708932T patent/ES2428746T3/es active Active
- 2010-03-11 PL PL10708932T patent/PL2406225T3/pl unknown
- 2010-03-11 KR KR1020117021314A patent/KR101674699B1/ko active IP Right Grant
- 2010-03-11 US US13/256,349 patent/US20120014918A1/en not_active Abandoned
- 2010-03-11 SG SG2011060811A patent/SG173823A1/en unknown
- 2010-03-11 JP JP2011553360A patent/JP5674685B2/ja active Active
- 2010-03-11 AU AU2010223528A patent/AU2010223528B2/en active Active
- 2010-03-11 DK DK10708932.8T patent/DK2406225T3/da active
- 2010-03-11 WO PCT/EP2010/001550 patent/WO2010102826A1/en active Application Filing
-
2011
- 2011-08-04 ZA ZA2011/05744A patent/ZA201105744B/en unknown
- 2011-08-08 IL IL214519A patent/IL214519A/en active IP Right Grant
- 2011-09-01 CO CO11112338A patent/CO6420337A2/es not_active Application Discontinuation
- 2011-09-08 CL CL2011002216A patent/CL2011002216A1/es unknown
- 2011-09-30 EC EC2011011365A patent/ECSP11011365A/es unknown
-
2012
- 2012-03-21 HK HK12102865.4A patent/HK1162487A1/xx unknown
-
2013
- 2013-09-11 HR HRP20130851AT patent/HRP20130851T1/hr unknown
- 2013-09-18 CY CY20131100818T patent/CY1114418T1/el unknown
- 2013-09-23 SM SM201300104T patent/SMT201300104B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130851T1 (hr) | Adicijske soli amina koji sadrže hidroksilne i/ili karboksilne grupe s derivatima aminonikotinske kiseline kao dhodh inhibitorima | |
| RS53839B1 (en) | SPIROCYCLES AS INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
| WO2010151710A3 (en) | Substituted heterocyclic compounds as kinases inhibitors and method of use thereof | |
| MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
| MX2014015501A (es) | Carboxamidas heterociclicas fungicidas. | |
| MX2009006408A (es) | Derivados de acidos amino-nicotinicos y amino-isonicotinico como inhibidores de dihidroorotato-deshidrogenasa. | |
| TW200833675A (en) | Nicotinamide derivatives | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| HK1153739A1 (en) | Spirocyclic derivatives as histone deacetylase inhibitors | |
| MX2015008971A (es) | Derivados de pirimidina pirido- o pirrolo-fusionados como inhibidores de autotaxina para tratar dolor. | |
| TW201129564A (en) | Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof | |
| WO2010007046A3 (en) | Heteroaryl derivatives as dgat1 inhibitors | |
| EA201170098A1 (ru) | Замещенные производные алкилпиримидин-4-она | |
| MX2010008362A (es) | Derivados de heteroarilamida diazepinopirimidona sustituidos. | |
| MX2009011769A (es) | Derivados de piridona como inhibidores de mapk p38a. | |
| MX2010008361A (es) | Derivados de arilamida oxazepinopirimidona sustituidos. | |
| MY159870A (en) | Piperazine compound capable of inhibiting prostaglandin d synthase | |
| MX2010008360A (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos. | |
| NZ712352A (en) | Novel inhibitors of glutaminyl cyclase | |
| TW200637539A (en) | CTGF inhibitors | |
| MX2009012380A (es) | Compuestos de heteroarilamida pirimidona. | |
| MX2013007938A (es) | Compuesto biciclico novedoso o sal del mismo. | |
| EA200700360A1 (ru) | Новые производные амида гетероциклической карбоновой кислоты | |
| MY150774A (en) | Isoquinoline derivative | |
| WO2010003084A3 (en) | Phosphodiesterase 4 inhibitors |